High quality reagents are the cornerstone of research and development. However, the logistics behind supporting researchers to access critical, high-quality reagents, like cell lines, in a timely manner can often be overwhelming, especially post-Brexit. There multiple challenges to overcome in sample management: managing the risk of non-compliance, overhead costs and long distribution timelines while maintaining sample integrity. This is where
Human biological samples are one of the most valuable resources when it comes to the progression of scientific research. Whether these samples are DNA, blood or tissue, they hold the answers needed to understand disease and unlock new therapies. As a result, the ability to correctly access, store and retrieve disease relevant human samples is an essential, yet often challenging,
Cell lines provide the foundation for scientific discovery. From the development of life-saving therapies to technological advancements, their quality directly dictates the reliability of findings, ensuring they lead to valid discoveries. However, without rigorous cell line quality control (QC), you risk compromising everything from data integrity to product safety, potentially wasting valuable time and resources. Cell line QC isn’t just
In life sciences, every sample has the potential to drive discoveries, critical diagnoses and vital therapeutic advancements. But without the proper care of these samples, even the most promising research can become flawed. At Biofortuna, we understand that safeguarding materials, be they biological specimens or reagents, is not just about storage. Instead, it’s about protecting your investment, timelines and the
Point of Care Testing delivers the accuracy of laboratory testing without the wait Speed is critical when diagnosing. Clinicians must treat or manage the issue quickly and effectively. This urgency is particularly vital in cases of viral infection. Will the patient need to go to hospital and, if so, do they need to be treated in an isolation ward? Should
When it comes to assay development and manufacturing, choosing the right Contract Development and Manufacturing Organisation (CDMO) is a critical decision that can significantly impact the success of your project. A CDMO’s expertise, capabilities, and approach can influence not only the quality of the final product but also the speed to market and regulatory compliance. Here are 10 key considerations